Diabetes Care 26:1941-1942, 2003
© 2003 by the American Diabetes Association, Inc.
Letters: Observations Letter |
The Effect of Oral Glucosamine Sulfate on Insulin Sensitivity in Human Subjects
Joseph G. Yu, MD1,2,3,
Sarah M. Boies, BS1,2,3 and
Jerrold M. Olefsky, MD1,2,3
1 Department of Medicine, Division of Endocrinology and Metabolism, University of California San Diego, La Jolla, California
2 Veterans Administration San Diego Healthcare System, San Diego, California
3 The Whittier Institute for Diabetes, La Jolla, California
| The first 20% of the full text of this article appears below. |
As glucosamine is presently in wide use due to its purported beneficial effects in patients with osteoarthritis, it seemed important to consider its possible adverse effects on glucose metabolism. Many subjects who take glucosamine for osteoarthritis are obese, insulin resistant, diabetic, or at risk for the development of diabetes, and it is established that glucosamine induces insulin resistance in rats and mice. Hypotheses suggest that glucosamine causes insulin resistance by directly entering the hexosamine biosynthetic pathway. It has been proposed that this provides a model for glucotoxicity-induced defects in insulin action and secretion (1), since, under hyperglycemic conditions, a larger amount of glucose flux is metabolized through the hexosamine pathway. Therefore, we undertook this study to determine if glucosamine, taken at recommended doses for the treatment of osteoarthritis, had . . . [Full Text of this Article]

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B A Biggee, C M Blinn, M Nuite, J E Silbert, and T E McAlindon
Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritis
Ann Rheum Dis,
February 1, 2007;
66(2):
260 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Muniyappa, R. J. Karne, G. Hall, S. K. Crandon, J. A. Bronstein, M. R. Ver, G. L. Hortin, and M. J. Quon
Oral Glucosamine for 6 Weeks at Standard Doses Does Not Cause or Worsen Insulin Resistance or Endothelial Dysfunction in Lean or Obese Subjects
Diabetes,
November 1, 2006;
55(11):
3142 - 3150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L Stumpf and S.-W. Lin
Effect of Glucosamine on Glucose Control
Ann. Pharmacother.,
April 1, 2006;
40(4):
694 - 698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Boullata
Natural Health Product Interactions with Medication
Nutr Clin Pract,
February 1, 2005;
20(1):
33 - 51.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
|